Iron status is an important cause of anemia in HIV-infected Tanzanian women but is not related to accelerated HIV disease progression

Journal of Nutrition

Volumn 137, Issue 10, 2007, Pages 2317-2323

  Kupka, Roland ^a   Msamanga, Gernard I ^b   Mugusi, Ferdinand ^b   Petraro, Paul ^a   Hunter, David J ^a   Fawzi, Wafaie W ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FOLIC ACID; HEMOGLOBIN; IRON; TRANSFERRIN RECEPTOR;

ANEMIA; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; MORTALITY; PROTEIN BLOOD LEVEL; TANZANIA;

EID: 34948902893     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/137.10.2317     Document Type: Article

References (47)

1. WHO/UNICEF/UNU. Iron deficiency anemia, assessment, prevention and control: a guide for programme managers. Geneva: WHO/NHD/01.3. WHO; 2001.
2. Stoltzfus R. Defining iron-deficiency anemia in public health terms: a time for reflection. J Nutr. 2001;131:S565-7.
3. Jurado RL. Iron, infections, and anemia of inflammation. Clin Infect Dis. 1997;25:888-95.
4. Cook JD. Defining optimal body iron. Proc Nutr Soc. 1999;58:489-95.
5. Friis H, Gomo E, Kastel P, Ndhlovu P, Nyazema N, Krarup H, Michaelsen KF. HIV and other predictors of serum folate, serum ferritin, and hemoglobin in pregnancy: a cross-sectional study in Zimbabwe. Am J Clin Nutr. 2001;73:1066-73.
6. Semba RD, Kumwenda N, Hoover DR, Taha TE, Mtimavalye L, Broadhead R, Eisinger W, Miotti PG, Chiphangwi JD. Assessment of iron status using plasma transferrin receptor in pregnant women with and without human immunodeficiency virus infection in Malawi. Eur J Clin Nutr. 2000;54:872-7.
7. Antelman G, Msamanga GI, Spiegelman D, Urassa EJ, Narh R, Hunter DJ, Fawzi WW. Nutritional factors and infectious disease contribute to anemia among pregnant women with human immunodeficiency virus in Tanzania. J Nutr. 2000;130:1950-7.
8. Asobayire FS, Adou P, Davidsson L, Cook JD, Hurrell RF. Prevalence of iron deficiency with and without concurrent anemia in population groups with high prevalences of malaria and other infections: a study in Cote dIvoire. Am J Clin Nutr. 2001;74:776-82.
9. Massawe SN, Urassa EN, Nystrom L, Lindmark G. Anaemia in women of reproductive age in Dar-es-Salaam, Tanzania. East Afr Med J. 2002;79:461-6.
10. O'Brien ME, Kupka R, Msamanga GI, Saathoff E, Hunter DJ, Fawzi WW. Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania. J Acquir Immune Defic Syndr. 2005;40:219-25.
11. Friis H, Gomo E, Nyazema N, Ndhlovu P, Krarup H, Madsen PH, Michaelsen KF. Iron, haptoglobin phenotype, and HIV-1 viral load: a cross-sectional study among pregnant Zimbabwean women. J Acquir Immune Defic Syndr. 2003;33:74-81.
12. Gordeuk VR, Onojobi G, Schneider MF, Dawkins FW, Delapenha R, Voloshin Y, von Wyl V, Bacon M, Minkoff H, et al. The association of serum ferritin and transferrin receptor concentrations with mortality in women with human immunodeficiency virus infection. Haematologica. 2006;91:739-43.
13. Costagliola DG, de Montalembert M, Lefrere JJ, Briand C, Rebulla P, Baruchel S, Dessi C, Fondu P, Karagiorga M, et al. Dose of desferrioxamine and evolution of HIV-1 infection in thalassaemic patients. Br J Haematol. 1994;87:849-52.
14. Salhi Y, Costagliola D, Rebulla P, Dessi C, Karagiorga M, Lena-Russo D, de Montalembert M, Girot R. Serum ferritin, desferrioxamine, and evolution of HIV-1 infection in thalassemic patients. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18:473-8.
15. de Monye C, Karcher DS, Boelaert JR, Gordeuk VR. Bone marrow macrophage iron grade and survival of HIV-seropositive patients. AIDS. 1999;13:375-80.
16. Delanghe JR, Langlois MR, Boelaert JR, Van Acker J, Van Wanzeele F, van der Groen G, Hemmer R, Verhofstede C, De Buyzere M, et al. Haptoglobin polymorphism, iron metabolism and mortality in HIV infection. AIDS. 1998;12:1027-32.
17. Weinberg GA. Iron overload as a mechanism for the lowered survival in AIDS patients receiving dapsone-iron protoxalate for secondary prophylaxis of Pneumocystis carinii pneumonia. J Infect Dis. 1996;174:241-2.
18. Fawzi WW, Msamanga GI, Spiegelman D, Urassa EJ, McGrath N, Mwakagile D, Antelman G, Mbise R, Herrera G, et al. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet. 1998;351:1477-82.
19. Fawzi WW, Msamanga GI, Spiegelman D, Urassa EJ, Hunter DJ. Rationale and design of the Tanzania Vitamin and HIV Infection Trial. Control Clin Trials. 1999;20:75-90.
20. WHO. Interim proposal for a WHO staging system for HIV infection and disease. Wkly Epidemiol Rec. 1990;65:221-4.
21. Johnson-Spear MA, Yip R. Hemoglobin difference between black and white women with comparable iron status: justification for race-specific anemia criteria. Am J Clin Nutr. 1994;60:117-21.
22. Kolbe-Busch S, Lotz J, Hafner G, Blanckaert NJ, Claeys G, Togni G, Carlsen J, Roddiger R, Thomas L. Multicenter evaluation of a fully mechanized soluble transferrin receptor assay on the Hitachi and cobas integra analyzers: the determination of reference ranges. Clin Chem Lab Med. 2002;40:529-36.
23. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448-54.
24. van den Broek NR, Letsky EA, White SA, Shenkin A. Iron status in pregnant women: which measurements are valid? Br J Haematol. 1998;103:817-24.
25. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood. 1997;89:1052-7.
26. Miettinen O. Theoretical epidemiology. New York: John Wiley & Sons; 1985.
27. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, FaNB Institute of Medicine. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academy Press; 2001.
28. Stoltzfus RJ, Dreyfuss ML, Chwaya HM, Albonico M. Hookworm control as a strategy to prevent iron deficiency. Nutr Rev. 1997;55:223-32.
29. van Lettow M, West CE, van der Meer JW, Wieringa FT, Semba RD. Low plasma selenium concentrations, high plasma human immunodeficiency virus load and high interleukin-6 concentrations are risk factors associated with anemia in adults presenting with pulmonary tuberculosis in Zomba district, Malawi. Eur J Clin Nutr. 2005;59:526-32.
30. Lipschitz DA, Cook JD, Finch CA. A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med. 1974;290:1213-6.
31. Boelaert JR, Weinberg GA, Weinberg ED. Altered iron metabolism in HIV infection: mechanisms, possible consequences, and proposals for management. Infect Agents Dis. 1996;5:36-46.
32. Kasvosve I, Gomo ZA, Nathoo KJ, Matibe P, Mudenge B, Loyevsky M, Nekhai S, Gordeuk VR. Association of serum transferrin receptor concentration with markers of inflammation in Zimbabwean children. Clin Chim Acta. 2006;371:130-6.
33. Kuvibidila S, Mark JA, Warrier RP, Yu L, Ode D, Tshefu KA. Soluble transferrin receptor as an index of iron status in Zairian children with malaria. J Trop Med Hyg. 1995;98:373-8.
34. Verhoef H, West CE, Ndeto P, Burema J, Beguin Y, Kok FJ. Serumtransferrin receptor concentration indicates increased erythropoiesis in Kenyan children with asymptomatic malaria. Am J Clin Nutr. 2001;74:767-75.
35. Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem. 2002;48:1066-76.
36. Lee EJ, Oh EJ, Park YJ, Lee HK, Kim BK. Soluble transferrin receptor (sTfR), ferritin, and sTfR/log ferritin index in anemic patients with nonhematologic malignancy and chronic inflammation. Clin Chem. 2002;48:1118-21.
37. Sappey C, Boelaert JR, Legrand-Poels S, Forceille C, Favier A, Piette J. Iron chelation decreases NF-kappa B and HIV type 1 activation due to oxidative stress. AIDS Res Hum Retroviruses. 1995;11:1049-61.
38. Hoffbrand AV, Ganeshaguru K, Hooton JW, Tattersall MH. Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells. Br J Haematol. 1976;33:517-26.
39. Schaible UE, Kaufmann SH. Iron and microbial infection. Nat Rev Microbiol. 2004;2:946-53.
40. Riera A, Gimferrer E, Cadafalch J, Remacha A, Martin S. Prevalence of high serum and red cell ferritin levels in HIV-infected patients. Haematologica. 1994;79:165-7.
41. Salmon-Ceron D, Fontbonne A, Saba J, May T, Raffi F, Chidiac C, Patey O, Aboulker JP, Schwartz D, et al. Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. Study Group. J Infect Dis. 1995;172:656-64.
42. Semba RD, Taha TE, Kumwenda N, Mtimavalye L, Broadhead R, Miotti PG, Chiphangwi JD. Iron status and indicators of human immunodeficiency virus disease severity among pregnant women in Malawi. Clin Infect Dis. 2001;32:1496-9.
43. Olsen A, Mwaniki D, Krarup H, Friis H. Low-dose iron supplementation does not increase HIV-1 load. J Acquir Immune Defic Syndr. 2004;36:637-8.
44. Eastham EJ, Bell JI, Douglas AP. Serum ferritin levels in acute hepatocellular damage from paracetamol overdosage. BMJ. 1976;1:750-1.
45. Beaton GH, McCabe GP. Efficacy of intermittent iron supplementation in the control of iron deficiency anaemia in developing countries: an analysis of experience. Ottawa: Micronutrient Initiative; 1999.
46. Weinberg GA, Friis H, Boelaert JR, Weinberg ED. Iron status and the severity of HIV infection in pregnant women. Clin Infect Dis. 2001;33:2098-100.
47. WHO. Iron supplementation of young children in regions where malaria transmission is intense and infectious disease highly prevalent. Geneva: WHO; 2006.